The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. This year’s metric has recorded a Price increase of 14.29%. However, over the past six months, we’ve seen a stronger performance of -22.99%. The price of LEGN fallen by 5.12% over the last 30 days. And in the last five days, it has surged by 9.45%.
In terms of market performance, Legend Biotech Corp ADR had a somewhat inconsistent run in. The highest value for the stock in the past year was $69.24 on 03/13/24, while the lowest value was $30.17 on 01/13/25.
52-week price history of LEGN Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Legend Biotech Corp ADR’s current trading price is -46.29% away from its 52-week high, while its distance from the 52-week low is 23.27%. The stock’s price range over this timeframe has been between $30.17 and $69.24. The shares of the Healthcare sector company recorded a trading volume of approximately 1.6 million for the day, which was comparatively higher than the average daily volume of 1.29 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Legend Biotech Corp ADR (LEGN) has experienced a quarterly decline of -10.73% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 6.82B and boasts a workforce of 1826 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 38.01, with a change in price of -12.49. Similarly, Legend Biotech Corp ADR recorded 1,442,637 in trading volume during the last 100 days, posting a change of -25.14%.
LEGN’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for LEGN stands at 0.31. Similarly, the long-term debt-to-equity ratio is also 0.31.
LEGN Stock Stochastic Average
Legend Biotech Corp ADR’s raw stochastic average for the past 50 days is currently at 71.41%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 61.16%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 37.71% and 29.49%, respectively.
